Alexander Mazein: Innovative Insights into Cytokine Release Syndrome via a Novel Explorable Model for Biotherapeutics and Cellular Therapies
Frontiers Immunology shared an innovative post from Alexander Mazein and researchers from Luxembourg Centre for System Biomedicine, University of Luxembourg, on X:
“New Research: An explorable model of an adverse outcome pathway of cytokine release syndrome related to the administration of immunomodulatory biotherapeutics and cellular therapies ”
Read the full article here:
Article: An explorable model of an adverse outcome pathway of cytokine release syndrome related to the administration of immunomodulatory biotherapeutics and cellular therapies
Authors: Alexander Mazein, Oxana Lopata, Kristin Reiche, Katherina Sewald, Miriam Alb, Christina Sakellariou, Patricia Gogesch, Hannah Morgan, Vanessa Neuhaus, Nhu-Nguyen Pham, Charline Sommer, Ethan Perkins, Birgit Fogal, Muhammad Shoaib, Reinhard Schneider, Venkata Satagopam, Marek Ostaszewski
Stay updated with Hemostasis Today.
-
May 27, 2026, 14:56Veronica Sanchez: Risk Factors and How to Recognize the Signs of Preeclampsia
-
May 27, 2026, 14:45Suvro Sankha Datta: New Frontiers in Platelet Transfusion and Preservation
-
May 27, 2026, 14:30Stacey Black Watson: A Meaningful Gathering Focused on Genetic Aortic and Vascular Conditions
-
May 27, 2026, 14:27Abdullah Mohsin: Possible Nursing Interventions for a Patient with DVT
-
May 27, 2026, 14:21Emmanuel J Favaloro: 100 Years of Von Willebrand disease
-
May 27, 2026, 14:20Noemy E. Diaz-Burgos: A Memorable Opening to the WFH Congress in Kuala Lumpur
-
May 27, 2026, 14:14Urgent Call for A and O Blood Donations! – Australian Red Cross Lifeblood
-
May 27, 2026, 14:06Augustina Isioma Ikusemoro: Why Routine Platelet Transfusion Is Not Always Recommended in Dengue
-
May 27, 2026, 13:56Suzan Osman: The Major Types of Intracranial Hemorrhage in Clinical Practice